Introduction {#s01}
============

In recent years, the importance of Z-discs, the protein-dense structures that anchor the antiparallel actin filaments from adjoining sarcomeres, in muscle has been underscored by the identification of a growing list of mutations in Z-disc proteins in patients with cardiac and skeletal muscle myopathies ([@bib17]; [@bib15]). The Enigma Homologue (ENH) protein belongs to the Enigma subfamily of the larger PDZ/LIM family of proteins, which also contains Enigma and Cypher/ZASP/Oracle ([@bib45]). Among members of this protein subfamily, comparatively little is known about the biological functions of the ENH protein.

To date, nine isoforms, which are produced via alternative splicing of the ENH transcript, have been identified ([@bib19]; [@bib27]; [@bib28]; [@bib8]). These isoforms are categorized based on the presence or absence of LIM domains at the C terminus. Whereas all ENH protein isoforms contain a single N-terminal PDZ domain, the "short" isoforms lack three C-terminal LIM domains present in "long" isoforms of the protein ([@bib27]; [@bib8]). The N-terminal PDZ domain binds α-actinin and promotes localization of ENH protein isoforms to the Z-discs in striated muscle ([@bib27]). Conversely, the LIM domains have been shown to interact with a number of important signaling proteins, including several kinases ([@bib19]; [@bib24]; [@bib43]). Long isoforms of the ENH protein have a ubiquitous tissue distribution ([@bib19]; [@bib40]), whereas the short isoforms are expressed predominantly in striated muscles ([@bib19]; [@bib28]).

Up to seven ENH isoforms (five long and two short isoforms) may be expressed in the heart ([@bib8]), with expression patterns that are developmentally regulated ([@bib42]). Long isoforms of ENH are highly expressed early in cardiac development, and the short isoforms predominate in the adult heart ([@bib42]), but reexpression of long ENH isoforms occurs in response to pressure overload ([@bib42]). Moreover, overexpression of ENH1/1a, a long isoform, in neonatal cardiomyocytes promotes the expression of hypertrophic markers and increases cell volume ([@bib42]), implicating the protein in the hypertrophic response. Altered expression of ENH was detected by RNA-seq in transgenic mice overexpressing PLN^R9C/+^, a model of dilated cardiomyopathy ([@bib4]). However, it was recently shown that cardiac-specific ablation of ENH isoform expression results in impaired myocardial function and dilated cardiomyopathy in the absence of activation of common cardiac stress pathways ([@bib8]). These findings suggest that the ENH protein may also have a role, either directly or indirectly, in regulating myocardial contractility. The results presented herein suggest that the ENH protein influences tension redevelopment kinetics in mouse myocardium, possibly by affecting cross-bridge cycling kinetics or the compliance of the Z-disc.

Materials and methods {#s02}
=====================

Transgenic mice {#s03}
---------------

Mice lacking cardiac-specific expression of ENH protein isoforms have been described previously ([@bib8]). *ENH*^−/−^ mice have a deletion in exon 3, which encodes part of the N-terminal PDZ domain present in all ENH protein isoforms; thus, *ENH*^−/−^ mice have cardiac-specific ablation of all ENH protein isoforms ([@bib8]). Two pairs of male and female *ENH*^+/−^ mice were obtained as a gift from Dr. J. Chen (University of California San Diego, La Jolla, CA). Mice were housed in clear plastic cages on a 12-h/12-h light/dark cycle with access to food and water ad libitum. Initial crossing of *ENH*^+/−^ mice produced *ENH*^+/+^, *ENH*^+/−^, and *ENH*^−/−^ animals at expected Mendelian ratios. *ENH*^−/−^ mice were obtained by intercrossing the *ENH*^−/−^ progeny resulting from the initial crosses. *ENH*^+/+^ mice were obtained from *ENH*^+/−^ crosses. Genotypes were determined from toe clips by PCR with the following primer sets: P1 (5′-GCAGGAAGCACACCCAGTAT-3′) versus P2 (5′-TGGTCTCCAACATTTCACCA-3′) to probe for the wild-type allele, and Frtneo (5′-AATGGGCTGACCGCTTCCTCGT-3′) versus P4 (5′-TCGGATGGATGCTCTCTTCT-3′) to probe for the knockout allele as described previously ([@bib8]). The genotypes of animals used for mechanical analyses were reconfirmed using tail snips after removal of hearts for pulling trabeculae. All procedures involving animal care and handling were reviewed and approved by the University of Wisconsin School of Medicine and Public Health Animal Care and Use Committee.

Solutions {#s04}
---------

The composition of solutions was calculated using the computer program of [@bib10] and the stability constants (corrected to pH 7.0 and 22°C) listed by [@bib12]. Unless otherwise stated, all solutions used for mechanical measurements contained (in mmol/liter) 100 BES, 15 creatine phosphate, 5 dithiothreitol, 1 free Mg^2+^, and 4 MgATP. In addition, (a) negative log of the calcium concentration (pCa) 9.0 solution contained 7 EGTA and 0.02 CaCl~2~, (b) pCa 4.5 solution contained 7 EGTA and 7.01 CaCl~2~, and (c) preactivating solution contained 0.07 EGTA. The ionic strength of all solutions was adjusted to 180 mmol/liter using potassium propionate. A range of solutions containing different amounts of \[Ca^2+^\]~free~ were prepared by mixing pCa 9.0 and pCa 4.5 solutions.

Skinned right ventricular trabeculae {#s05}
------------------------------------

Right ventricular trabeculae (*n* = 15 for *ENH*^+/+^; *n* = 20 for *ENH*^−/−^) were isolated as described previously ([@bib29]; [@bib31]). Briefly, hearts were excised from *ENH*^+/+^ (*n* = 11) and *ENH*^−/−^ (*n* = 12) mice of either sex (3--6 mo of age) previously injected (intraperitoneal injection) with 5,000 U heparin/kg body weight, anesthetized with isoflurane, and pinned down to the base of a dissecting dish filled with modified Ringer's solution (in mmol/liter: 120 NaCl, 19 NaHCO~3~, 1.2 Na~2~HPO~4~, 1.2 MgSO~4~, 5 KCl, 1 CaCl~2~, and 10 glucose, pH 7.4, 22°C) preequilibrated with 95% O~2~/5% CO~2~. The right ventricles were cut open and exposed to fresh Ringer's solution containing 20 mmol/liter 2,3-butanedione monoxime for 30 min (1× solution change). The unbranched right ventricular trabeculae were then dissected free, tied to sticks to hold muscle length fixed, and transferred to relaxing solution (in mmol/liter: 100 KCl, 20 imidazole, 7 MgCl~2~, 2 EGTA, and 4 ATP, pH 7.0, 4°C) containing 1% Triton X-100 and 0.25 g/ml saponin. After skinning overnight, the trabeculae were washed in fresh relaxing solution (∼1 h) and then stored at −20°C in relaxing solution containing glycerol (50:50 vol/vol). The left and right ventricles were separated at the septum, frozen in liquid nitrogen, and stored at −80°C for later analysis by top-down proteomics.

Experimental apparatus and protocols {#s06}
------------------------------------

On the day of an experiment, skinned trabeculae were washed in relaxing solution for 30 min before cutting them free from the sticks and trimming their ends. The trimmed trabeculae were then transferred to a stainless steel experimental chamber containing pCa 9.0 solution ([@bib26]). The ends of each trabecula were attached to the arms of a motor (model 312B; Aurora Scientific) and force transducer (model 403; Aurora Scientific), as described earlier ([@bib26]). The chamber assembly was then placed on the stage of an inverted microscope (Olympus) fitted with a 40× objective and a CCTV camera (model WV-BL600; Panasonic). The light from a halogen lamp was used to illuminate the skinned preparations. Bitmap images of the preparations were acquired using an AGP 4X/2X graphics card, as well as associated software (ATI Technologies), and were used to assess mean sarcomere length (SL) during the course of each experiment. Changes in tension and motor position were sampled (16-bit resolution, DAP5216a; Microstar Laboratories) at 2.0 kHz using SLControl software developed in this laboratory (<http://www.slcontrol.com>; [@bib5]). Data were saved to computer files for later analysis.

Active tension--pCa and rate constant of tension redevelopment (*k*~tr~)--pCa/tension relationships were established at SL 2.2 µm as described previously ([@bib31]). Briefly, the skinned trabeculae were stretched to a mean SL of ∼2.2 µm in pCa 9.0 solution. After measuring length and width, the preparations were transferred first to preactivating solution, then to Ca^2+^ activating solution, and finally back to pCa 9.0 solution. Once in Ca^2+^ activating solution, steady-state tension and *k*~tr~ were measured simultaneously using the modified multistep protocol developed by [@bib3], described in detail previously ([@bib30]), and illustrated in [Fig. 1 A](#fig1){ref-type="fig"}. Briefly, after tension reached a steady level in activating solution (pCa 6.2--4.5), the length of the preparation was rapidly reduced by ∼20%, held for ∼14 ms, and then restretched back to its original length. As a result of restretch, there was an initial transient increase, followed by a decrease in tension (seen as a spike in the tension trace) and subsequent slow recovery of tension nearing the initial steady-state level. The *k*~tr~ reported in the present study is the rate constant of tension redevelopment after the spike. The drop in tension recorded in solution of pCa 9.0 was taken as passive tension and was therefore subtracted from the drop in total tension at each pCa to yield the Ca^2+^-activated tension (P). The protocol was repeated to establish active tension--pCa and *k*~tr~--pCa/relative active tension relationships. Upon completing mechanical measurements, the trabeculae were cut free at the points of attachment, placed in urea/thiourea SDS sample buffer, and stored at −80°C until subsequent protein analysis.

![**Loss of ENH protein expression does not alter steady-state mechanical properties of mouse myocardium. (A)** Experimental protocol for simultaneous determination of Ca^2+^-activated tension and *k*~tr~. **(B and C)** The passive (B) and maximum (C) Ca^2+^-activated tension generated by skinned right ventricular trabeculae isolated from the hearts of *ENH*^+/+^ and *ENH*^−/−^ mice. **(D)** Tension--pCa relationships established in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. **(E and F)** The Hill coefficient (E) and pCa~50~ (F) values established in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. Each data point is the mean and error bar the SEM.](JGP_201812214_Fig1){#fig1}

To ensure that the differences in mechanical properties between *ENH*^+/+^ and *ENH*^−/−^ myocardium were not confounded by the differential expression of key contractile proteins, the trabeculae stored in sample buffer were electrophoresed using 5% and 12.5% Tris-HCl Precast Criterion gels (Bio-Rad) as described previously ([@bib41]). The gels were silver stained using methods described previously ([@bib34]) with minor modifications ([@bib36]) as follows: the gels were (a) incubated for 20 min in fixing solution containing 50% methanol and 10% acetic acid, (b) washed for 20 min (4× ddH~2~O changes) with ddH~2~O, (c) incubated for 1.5 min in 0.01% sodium thiosulfate solution and then rinsed 4× with ddH~2~O, (d) incubated for 20 min in 0.09% silver nitrate solution and then rinsed 4× with ddH~2~O, (e) incubated in developing solution containing 0.0004% sodium thiosulfate, 2% potassium carbonate, and 0.0068% formaldehyde until proteins were visible and then rinsed 4× with ddH~2~O, (f) incubated for 20 min in destaining solution containing 10% methanol and 10% acetic acid, rinsed 4× in ddH~2~O, and (g) finally washed for 30 min (6× ddH~2~O changes) with ddH~2~O. The gels were then scanned and protein bands quantified using a Bio-Rad Chemi Doc MP Imaging System.

Sample preparation for proteomics analysis {#s07}
------------------------------------------

Frozen left ventricular myocardium from *ENH*^+/+^ (*n* = 8) and *ENH*^−/−^ (*n* = 13) mice was homogenized in ∼25× (wt/vol) HEPES extraction buffer containing (in mmol/liter) 25 HEPES, pH 7.5, 100 sodium fluoride, 5 sodium pyrophosphate, 50 β-glycerophosphate, 5 Na~3~VO~4~, 2.5 EDTA, and 1× protease inhibitor cocktail (Sigma) using a Polytron electric homogenizer (Model PRO200; PRO Scientific) on ice with 3--4-s bursts. The resulting homogenates were centrifuged at 21,000 *g* for 20 min at 4°C, and the supernatants were discarded. The insoluble pellets were subsequently rehomogenized in 3× (wt/vol) trifluoroacetic acid (TFA) solution (containing 1% TFA and 10 mmol/liter Tris(2-carboxyethyl)phosphine \[TCEP\]) to extract a protein fraction enriched in sarcomeric proteins. After centrifugation (21,000 *g*, 4°C, 30 min), the supernatants were transferred to new microcentrifuge tubes, taking care not to disturb the pellet, and centrifuged an additional time (21,000 *g*, 4°C, 90 min) to ensure complete removal of all particulate matter from the samples. After careful collection of the supernatant, the protein concentration of individual samples was determined using the Pierce Coomassie Plus (Bradford) Assay Kit (Thermo Fisher Scientific) in accordance with the manufacturer's instructions. A single *ENH*^+/+^ sample was randomly chosen, and six dilutions were prepared with the following total protein concentrations (in ng): 50, 100, 250, 400, 500, and 750. These samples were used to verify that the measured protein intensities fell within the linear response range for the mass spectrometer (Fig. S1). The remaining samples were diluted to a final total protein concentration of 400 ng. All samples were diluted in HPLC-grade water containing 0.1% formic acid and 10 mmol/liter TCEP.

Top-down proteomics {#s08}
-------------------

Diluted protein extracts prepared from the left ventricular myocardium of *ENH*^+/+^ (*n* = 8) and *ENH*^−/−^ (*n* = 13) mice were separated using a NanoAcquity ultra-high pressure liquid chromatography system (Waters), equipped with a home-packed PLRP column (PLRP-S, 250 mm × 500 µm, 10-µm particle size, 1,000-Å pore size; Varian), coupled directly online with a high-resolution Impact II Q-TOF mass spectrometer (Bruker Daltonics). Proteins were eluted using a gradient going from 5% B to 95% B over 55 min (solvent A: 0.10% formic acid in water; solvent B: 0.10% formic acid in a 50:50 mixture of acetonitrile and ethanol) at a flow rate of 8 µl/min. Spectra were collected using a scan rate of 1 Hz over a 500--3,000 *m*/*z* range. Chromatographic separation and protein signal intensities (Fig. S2), as well as the relative intensity ratios of unmodified and modified protein forms (Fig. S3), were highly reproducible across replicates.

Data analysis {#s09}
-------------

The cross-sectional areas of skinned trabeculae were calculated by assuming that the trabeculae were cylindrical and by equating the width, measured from video images of the mounted preparations, to diameter. Each tension (P) at pCa between 6.2 and 5.4 was expressed as a fraction of the maximum Ca^2+^-activated tension (P~o~) developed by the same preparations at pCa 4.5, i.e., P/P~o~. To determine the concentration of Ca^2+^ at half-maximal activation (pCa~50~), tension--pCa data were fitted with the Hill equation: P/P~o~ = \[Ca^2+^\]^n^/(*k*^n^ + \[Ca^2+^\]^n^)\], where n is the slope (Hill coefficient; n~H~) of the fitted curve and *k* is the pCa~50~. *k*~tr~ was determined by linear transformation of the half-time of tension recovery (*k*~tr~ = −ln 0.5 × (t~1/2~)^−1^), as described previously ([@bib7]; [@bib30]).

All MS data were analyzed using DataAnalysis (Bruker Daltonics). To quantify the relative abundances of unmodified and modified protein forms, spectra were averaged across the entire width of the chromatographic peaks corresponding to elution of the protein of interest, deconvoluted using Maximum Entropy, and processed using the SNAP function in DataAnalysis, which yielded a mass list containing intensity values for each detected protein species in the specified chromatographic time frame. The total protein population intensity was determined by summing the intensity values for all unmodified and modified species corresponding to the same protein. Subsequently, the relative abundance (expressed as a percentage of the total population intensity) of each individual form of that specific protein was determined by dividing the summed intensities of all species corresponding to a specific protein form by the total population intensity for that protein and multiplying by 100%. Protein phosphorylation levels were determined using the relative abundance values calculated for all differentially phosphorylated species from the same protein using the following equation: P~total~ = (%P~mono~ + (2 × %P~bis~) + (3 × %P~tris~) + ...)/100, as described previously ([@bib9]; [@bib32]; [@bib14]).

For the MS-based quantification of sarcomeric protein expression levels in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium, extracted ion chromatograms (EICs) were generated for individual sarcomeric proteins from each sample in DataAnalysis by inputting all protein forms corresponding to a specific protein of interest for the top five most abundant charge states. A line was then manually drawn under the EIC generated for a given sarcomeric protein using the Chromatogram Compounds Manually function in DataAnalysis. This procedure yielded an area value corresponding to the area under the curve, which represented the relative expression of the specific protein.

All data are presented as means ± SEM. Data were not normally distributed; thus, statistical significance was assessed using the nonparametric two-tailed Mann--Whitney *U* test. P values \<0.05 were considered significant.

Online supplemental material {#s10}
----------------------------

Also included are the linear response ranges for individual sarcomeric proteins (Fig. S1), the reproducibility of the chromatographic separation and sarcomeric protein mass spectrometry signal intensities (Fig. S2), the reproducibility of protein phosphorylation measurements by top-down proteomics (Fig. S3), and SDS-PAGE analysis of thin/thick filament regulatory protein expression in *ENH*^+/+^ and *ENH*^−/−^ trabeculae (Fig. S4).

Results {#s11}
=======

Loss of ENH protein expression does not alter the steady-state contraction or mechanical properties of mouse myocardium {#s12}
-----------------------------------------------------------------------------------------------------------------------

To determine whether ablation of ENH protein expression affects the mechanical properties of mouse myocardium, trabeculae were isolated from the hearts of *ENH*^+/+^ and *ENH*^−/−^ mice and skinned, and the steady-state tension and *k*~tr~ were measured simultaneously using the modified multistep protocol developed by [@bib3], described in detail previously ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib30]). Although skinned trabeculae from *ENH*^+/+^ and *ENH*^−/−^ mice generated similar amounts of passive tension (pCa 9.0; [Fig. 1 B](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}), there was a trend toward decreased maximum Ca^2+^-activated tension (pCa 4.5) in *ENH*^−/−^ trabeculae, although this trend did not reach statistical significance (P = 0.051; [Fig. 1 C](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). The tension--pCa relationships measured in *ENH*^+/+^ and *ENH*^−/−^ trabeculae were sigmoidal and were fitted with a Hill equation (as described in Materials and methods) to yield n~H~, an index of apparent cooperativity in the activation of tension, and pCa~50~, a measure of the Ca^2+^ sensitivity of tension. The obtained tension--pCa relations, as well as the derived values for n~H~ and pCa~50~, did not differ between *ENH*^+/+^ and *ENH*^−/−^ trabeculae ([Fig. 1, D--F](#fig1){ref-type="fig"}; and [Table 1](#tbl1){ref-type="table"}).

###### Summary of mechanical properties of right ventricular trabeculae isolated from the hearts of *ENH*^+/+^ and *ENH*^−/−^ mice

  Number of trabeculae   Passive tension (mN/mm^2^)   Maximum Ca^2+^ activated tension (mN/mm^2^)   Hill coefficient (n~H~)   Ca^2+^ sensitivity of tension (pCa~50~)   Maximum rate of tension redevelopment (s^−1^)
  ---------------------- ---------------------------- --------------------------------------------- ------------------------- ----------------------------------------- --------------------------------------------------
  *ENH*^+/+^, *n* = 15   1.83 ± 0.17                  22.34 ± 1.85                                  2.69 ± 0.06               5.73 ± 0.01                               32.33 ± 1.94
  *ENH*^−/−^, *n* = 20   2.06 ± 0.18                  17.85 ± 1.48                                  2.69 ± 0.04               5.75 ± 0.01                               19.80 ± 1.17[^a^](#ttbl1n2){ref-type="table-fn"}

The mechanical properties of skinned trabeculae isolated from the right ventricles of *ENH*^+/+^ (*n* = 11) and *ENH*^−/−^ (*n* = 12) mice were examined at SL 2.2 µm and 22°C. Passive tension was measured at pCa 9.0. P~o~ and *k*~tr~ were measured at pCa 4.5. pCa~50~ and n~H~ values were derived by fitting the tension--pCa relationships to a Hill equation as described in Materials and methods.

The measured values were significantly different (P \< 0.05) from values recorded in *ENH*^+/+^ trabeculae.

ENH ablation slows kinetics in mouse myocardium, an effect that involves changes in the rates of cross-bridge attachment and detachment {#s13}
---------------------------------------------------------------------------------------------------------------------------------------

Trabeculae from *ENH*^+/+^ and *ENH*^−/−^ mice exhibited \[Ca^2+^\]~free~-dependent (and tension-dependent) changes in *k*~tr~. To illustrate this, records of tension redevelopment in *ENH*^+/+^ and *ENH*^−/−^ trabeculae at various levels of \[Ca^2+^\]~free~ (and tension) are shown in [Fig. 2, A and B](#fig2){ref-type="fig"}, where steady-state tension at each pCa was normalized to 1.0 to provide better visualization of changes in the kinetics of tension redevelopment. Compared with *ENH*^+/+^ trabeculae, *ENH*^−/−^ trabeculae redeveloped tensions at a significantly slower rate at both submaximal and maximal \[Ca^2+^\]~free~ ([Fig. 2, A--C](#fig2){ref-type="fig"}; and [Table 1](#tbl1){ref-type="table"}). When *k*~tr~ values were replotted against steady-state isometric tension (as a function of maximum tension), the curvilinear *k*~tr~--relative tension relationships measured in *ENH*^−/−^ trabeculae were shifted to the right (to higher \[Ca^2+^\]~free~) relative to those established in *ENH*^+/+^ trabeculae ([Fig. 2 D](#fig2){ref-type="fig"}).

![**Ablation of ENH protein expression slows tension redevelopment kinetics in mouse myocardium. (A and B)** Representative tension redevelopment traces at different \[Ca^2+^\]~free~ in skinned right ventricular trabeculae isolated from the hearts of *ENH*^+/+^ (A) and *ENH*^−/−^ (B) mice. **(C)** *k*~tr~--pCa relationships established in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. **(D)** *k*~tr~--relative tension relationship established in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. **(E)** In(*k*~tr~)--relative tension relationships established in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. The natural logarithm of mean *k*~tr~ values were plotted against relative tension, and the regression fitted to the data yielded y intercepts of 1.60 (g~app~ = 4.94 s^−1^) and 1.14 (g~app~ = 3.33 s^−1^) for *ENH*^+/+^ and *ENH*^−/−^ trabeculae, respectively. Each data point is the mean and error bar the SEM.](JGP_201812214_Fig2){#fig2}

The deletion of ENH-induced reduction in *k*~tr~ values may involve a decrease in either the rate of attachment of myosin heads with actin (*f*~app~) or the rate of detachment of myosin head from actin (*g*~app~), or both. Considering the two-state cross-bridge model suggesting that myosin cross-bridges are either attached to the thin filament and generating tension (in which case *k*~tr~ = *f*~app~ + *g*~app~) or detached and not generating tension (in which case *k*~tr~ = *g*~app~); it is possible to estimate *g*~app~ by extrapolating either the curvilinear *k*~tr~--tension relationship ([Fig. 2 D](#fig2){ref-type="fig"}) or the ln\[*k*~tr~\]--tension relationship to zero tension, i.e., to the y axis ([@bib3]; [@bib2]). Here we chose the latter method to determine whether ENH deletion affects *g*~app~ ([Fig. 2 E](#fig2){ref-type="fig"}). The natural logarithms of mean *k*~tr~ values were plotted against relative tensions and extrapolated with a linear regression fit to the y axis. The *g*~app~ values thus determined for *ENH*^+/+^ and *ENH*^−/−^ trabeculae were 4.94 and 3.33 s^−1^, respectively. Knowing the maximum value of *k*~tr~ ([Table 1](#tbl1){ref-type="table"}) and *g*~app~ for *ENH*^+/+^ and *ENH*^−/−^ trabeculae, we calculated *f*~app~ using the equation *k*~tr~ = *f*~app~ + *g*~app~ to be 27.39 s^−1^ for *ENH*^+/+^ trabeculae and 16.47 s^−1^ for *ENH*^−/−^ trabeculae. These results suggest that deletion of ENH protein in mouse myocardium is likely to reduce the rate of cross-bridge attachment by as much as ∼40% and rate of detachment by ∼33%.

The relative expression of β-myosin heavy chain (β-MHC), but not other thin/thick filament regulatory proteins, is altered in the myocardium of *ENH*^−/−^ mice relative to that in *ENH*^+/+^ mice {#s14}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Tension redevelopment kinetics are determined fundamentally by the expression of MHC isoforms ([@bib21]; [@bib11]), and thus we assessed the relative expression of α- and β-MHC in trabeculae from *ENH*^+/+^ and *ENH*^−/−^ mice. In *ENH*^+/+^ trabeculae, α-MHC and β-MHC accounted for 96.2 ± 1.1% and 3.8 ± 1.1%, respectively, of the total MHC; while in *ENH*^−/−^ trabeculae these isoforms accounted for 87.9 ± 2.3% and 12.1 ± 2.3%, respectively, of total MHC ([Fig. 3 A](#fig3){ref-type="fig"}). The expression of the slow isoform (β-MHC) was increased by ∼8% in trabeculae from *ENH*^−/−^ compared with *ENH*^+/+^ trabeculae (P \< 0.05; [Fig. 3 A](#fig3){ref-type="fig"}).

![**The expression of MHC isoforms, but not other thin/thick filament regulatory proteins, is altered in *ENH*^−/−^ mouse myocardium. (A)** Representative silver-stained gels showing expression profile of myosin heavy chain isoforms (top) and associated quantification (bottom) in *ENH*^+/+^ and *ENH*^−/−^ trabeculae. **(B)** Zoomed-in deconvoluted mass spectrum showing ENH protein species detected in *ENH*^+/+^, but not *ENH*^−/−^, mouse myocardium. Star denotes potential acetylated form of *~p~*ENH3b (ΔM = 42.00 Da). **(C--J)** Top-down proteomics quantification of thin/thick filament protein expression in the ventricular myocardium of *ENH*^+/+^ and *ENH*^−/−^ mice. Each data point is the mean and error bar the SEM.](JGP_201812214_Fig3){#fig3}

We next determined whether the expression of other thin/thick filament regulatory proteins was altered in the myocardium of *ENH*^−/−^ mice. Quantitative top-down proteomics was employed to assess the relative expression of these proteins in the myocardium of *ENH*^+/+^ and *ENH*^−/−^ mice. Proteomics analysis of sarcomere protein-enriched extracts permitted highly reproducible quantification of the expression of thin/thick filament regulatory proteins, including cardiac troponin T (cTnT) isoforms, cardiac troponin I (cTnI), troponin C, α-tropomyosin (αTpm), myosin essential light chain (ELC~v~), and myosin regulatory light chain (RLC~v~), in the myocardium of *ENH*^+/+^ and *ENH*^−/−^ mice (Fig. S2). Top-down proteomics analysis also enabled the detection of two short isoforms of ENH (ENH3a and ENH3b; [@bib8]) in mouse myocardium and confirmed ablation of ENH isoform expression in *ENH*^−/−^ mouse myocardium ([Fig. 3 B](#fig3){ref-type="fig"}). No differences in the expression of thin/thick filament regulatory proteins were detected in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium by top-down proteomics analysis ([Fig. 3, C--J](#fig3){ref-type="fig"}). The top-down proteomics data were corroborated by results from SDS-PAGE analysis of thin/thick filament regulatory protein expression in trabeculae from *ENH*^+/+^ and *ENH*^−/−^ mice (Fig. S4).

The phosphorylations of a cTnT isoform, cTnI, and RLC~v~ are reduced in the myocardium of *ENH*^−/−^ mice relative to *ENH*^+/+^ mouse myocardium {#s15}
-------------------------------------------------------------------------------------------------------------------------------------------------

Since contractile protein phosphorylation can also regulate tension redevelopment kinetics ([@bib18]; [@bib35],[@bib36]; [@bib22]; [@bib38]), the phosphorylation status of thin/thick filament regulatory proteins in the ventricular myocardium of *ENH*^+/+^ and *ENH*^−/−^ mice was also reproducibly determined using top-down proteomics (Fig. S3). Representative zoomed-in deconvoluted mass spectra with detected cTnT, cTnI, αTpm, and RLC~v~ protein species in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium are shown in [Fig. 4](#fig4){ref-type="fig"}. Analysis of sarcomeric protein phosphorylation in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium showed that, while the phosphorylation of cTnT isoforms A2 (cTnT-A2) and A1 (cTnT-A1), as well as αTpm, did not differ, the phosphorylation of cTnT isoform A3B (cTnT-A3B), cTnI, and RLC~v~ were significantly decreased in the myocardium of *ENH*^−/−^ mice (relative to that in *ENH*^+/+^ mouse myocardium; [Fig. 5](#fig5){ref-type="fig"}). Specifically, the phosphorylations of cTnT-A3B, cTnI, and RLC~v~ were decreased by ∼6% (P \< 0.05), 12% (P \< 0.01), and 25% (P \< 0.01), respectively, in *ENH*^−/−^ mouse myocardium ([Fig. 5](#fig5){ref-type="fig"}). The relative abundance of the bis-phosphorylated form of cTnI (*~pp~*cTnI) was decreased by ∼10% in the myocardium of *ENH*^−/−^ mice (P \< 0.01 versus relative abundance in *ENH*^+/+^ mouse myocardium; [Fig. 5 E](#fig5){ref-type="fig"}).

![**Top-down proteomic analysis of contractile protein phosphorylation in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium. (A--D)** Representative zoomed-in deconvoluted mass spectra showing the relative intensities of unmodified and modified forms of cTnT isoforms (A), cTnI (B), αTpm (C), and RLC~v~ (D) in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium. Reported masses are the most abundant masses. Squares, stars, and diamonds denote peaks corresponding to proteins associated noncovalently with phosphoric acid (+H~3~PO~4~), proteins associated noncovalently with sodium ions (+Na^+^), and proteins displaying a 62-Da mass increase relative to the unmodified and modified protein species, respectively.](JGP_201812214_Fig4){#fig4}

![**The phosphorylation of cTnT-A3B, cTnI, and RLC~v~ is decreased in *ENH*^−/−^ mouse myocardium. (A--D)** Quantification of cTnT isoform (A--C) and cTnI (D) phosphorylation in the ventricular myocardium of *ENH*^+/+^ and *ENH*^−/−^ mice. **(E)** Relative abundance of *~pp~*cTnI in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium. **(F and G)** Quantification of αTpm (F) and RLC~v~ (G) phosphorylation in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium. Each data point is the mean and error bar the SEM.](JGP_201812214_Fig5){#fig5}

Discussion {#s16}
==========

The results of the present study demonstrate that ablation of ENH protein expression slows tension redevelopment kinetics in mouse myocardium. In mammalian cardiac muscle, tension redevelopment kinetics are determined fundamentally by the expression of MHC isoforms ([@bib21]; [@bib11]). The relative expression of the slow isoform, β-MHC, was significantly increased in *ENH*^−/−^ trabeculae. This finding is in agreement with previous results showing an up-regulation of β-MHC at the messenger RNA level in *ENH*^−/−^ mouse myocardium ([@bib8]) and suggests that increased expression of β-MHC contributes to slowed tension redevelopment kinetics in the myocardium of these mice. Prior studies have demonstrated that a linear relationship exists between the expression of β-MHC and *k*~tr~ in rat and mouse ventricular myocardium ([@bib21]; [@bib11]). Based on the linear relationships established in those studies, the 8% increase in β-MHC in *ENH*^−/−^ mouse myocardium would be expected to reduce *k*~tr~ by ∼8--10%, indicating that the observed increase in β-MHC in *ENH*^−/−^ mouse myocardium contributes to slowed contraction kinetics but is insufficient to explain the ∼40% decrease in *k*~tr~. Furthermore, such low-level expression of β-MHC only affects tension redevelopment kinetics at high levels of activation (unpublished observations) and, thus, a modest increase in β-MHC expression cannot explain the pronounced reduction in *k*~tr~ at low levels of \[Ca^2+^\]~free~ observed here. Collectively, this information argues against increased expression of β-MHC as a major factor underlying the decreased *k*~tr~ in *ENH*^−/−^ mouse myocardium. Since the expression of other thin/thick filament regulatory proteins did not differ in *ENH*^+/+^ and *ENH*^−/−^ mouse myocardium, the ENH deletion-induced decrease in *k*~tr~ is unlikely to be due to changes in the expression of other contractile proteins.

Tension redevelopment kinetics can also be modulated by the phosphorylation of contractile proteins such as cMyBP-C ([@bib18]; [@bib35]; [@bib22]), cTnT ([@bib13]; [@bib25]), and RLC~v~ ([@bib29]; [@bib36]; [@bib38]). Using top-down proteomics, we identified significant reductions in the phosphorylation of cTnT-A3B (∼6%), cTnI (∼12%), and RLC~v~ (∼25%) in *ENH*^−/−^ mouse myocardium. Based on prior studies ([@bib1]; [@bib33]; [@bib44]), reduced phosphorylation of cTnT-A3B, cTnI, and RLC~v~ likely occurs at Ser^1^, Ser^22/23^, and Ser^14/15^, respectively. Reconstitution of mouse cardiac muscle fibers with pseudo-phosphorylated cTnT (T203E) has previously been shown to reduce *k*~tr~ by decreasing *g*~app~ in an α-MHC background ([@bib25]). Therefore, reduced phosphorylation of cTnT in *ENH*^−/−^ myocardium would be expected to increase *k*~tr~ (by increasing *g*~app~), arguing against a role for reduced cTnT phosphorylation in slowed tension redevelopment kinetics in the myocardium of *ENH*^−/−^ mice. The observed decrease in cTnI phosphorylation in *ENH*^−/−^ myocardium would not be expected to affect *k*~tr~ ([@bib37]), although an increase in the Ca^2+^ sensitivity of tension would be anticipated. A possible explanation for unaltered Ca^2+^ sensitivity of tension in *ENH*^−/−^ trabeculae is that the effect of reduced cTnI phosphorylation may have been counteracted by an effect of reduced RLC~v~ phosphorylation (i.e., decreased Ca^2+^ sensitivity of tension; [@bib29]; [@bib36]; [@bib38]), which was also observed in these mice. In contrast to alterations in cTnT-A3B and cTnI phosphorylation, decreased RLC~v~ phosphorylation (∼25%) in *ENH*^−/−^ mouse myocardium could contribute to slowed tension redevelopment kinetics in the myocardium of *ENH*^−/−^ mice ([@bib29]; [@bib36]; [@bib38]). Yet, decreased RLC~v~ phosphorylation should also produce concomitant decreases in the Ca^2+^ sensitivity of tension and maximal tension ([@bib29]; [@bib36]; [@bib38]). While decreased Ca^2+^ sensitivity of tension may be offset by the effect of reduced cTnI phosphorylation as suggested above, a significant decrease in maximal tension was not detected in *ENH*^−/−^ trabeculae. Together, this information indicates that aside from decreased RLC~v~ phosphorylation, which could contribute to decreased *k*~tr~, the observed changes in contractile protein phosphorylation do not explain slowed tension redevelopment kinetics in *ENH*^−/−^ mouse myocardium. The possibility that alterations in the expression or phosphorylation of other sarcomeric proteins (i.e., those not analyzed in this study) contribute to slowed tension redevelopment kinetics in *ENH*^−/−^ mouse myocardium must be acknowledged; however, the findings of the present study indicate that removal of the ENH protein from the Z-disc directly underlies depressed tension redevelopment kinetics in *ENH*^−/−^ mouse myocardium. Moreover, our *k*~tr~ data suggest that removal of the ENH protein slows tension redevelopment kinetics by decreasing cross-bridge cycling kinetics.

An alternative possibility is that loss of ENH expression slows tension redevelopment kinetics by increasing the compliance of sarcomeres. Prior studies have shown that cardiac-specific ablation of MLP, a LIM domain--containing protein that localizes to the Z-disc, increases the width of Z-disc ([@bib16]) and reduces passive tension. Even though a similar increase in the width of Z-discs in the myocardium of *ENH*^−/−^ mice has been reported previously ([@bib8]), we did not observe a decrease in passive force in the present study. A more recent study of *MLP*^−/−^ mice also reported no change in passive tension, a decreased rate of cross-bridge detachment (*g*~app~), and no change in the Ca^2+^ sensitivity of tension; however, a decrease in maximal tension was also noted ([@bib20]). Although we did not detect a significant change in maximal tension in *ENH*^−/−^ myocardium, the possibility that removal of the ENH protein introduces a compliance within the sarcomeres, similar to that induced by MLP removal, cannot be excluded.

It was recently demonstrated that the giant protein nebulin, which is anchored in the Z-disc but spans the length of the thin filament, has a role in determining the rate of cross-bridge cycling, as well as the Ca^2+^ sensitivity and cooperativity of activation, in skeletal muscle ([@bib6]). Notably, the width of Z-discs is also increased in skeletal muscles lacking nebulin ([@bib39]). However, the effects of nebulin on contractility are likely mediated by direct modulation of actin--myosin interactions by the portion of the protein that extends into the A band ([@bib6]). Supporting this conclusion is the fact that ablation of nebulette, the short cardiac-specific isoform of nebulin, which is also anchored in the Z-disc but does not span the thin filament, does not alter the steady-state or dynamic mechanical properties of mouse myocardium ([@bib23]). Therefore, it is unclear at this point how a protein such as ENH, which is within the Z-disc ([@bib27]), could influence actin--myosin interactions in the A band. One possible explanation is that the structural changes occurring within the Z-disc upon ENH removal ([@bib8]) alter the spatial orientation of the actin filaments with respect to the myosin filaments. As a result, the myosin heads may exhibit slower attachment to and/or detachment from binding sites on the thin filament, thereby slowing cross-bridge cycling kinetics. Although our findings provide the first evidence that the ENH protein influences tension redevelopment kinetics in mouse myocardium, further studies such as sinusoidal analysis and tension--velocity curves will nonetheless be necessary to fully understand the role of ENH as a determinant of myocardial contractility.
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